Skin structural components

Skin structural components refer to the complex network of proteins and macromolecules that constitute the physical architecture of the skin, primarily located within the epidermis and dermis (StatPearls, 2023). The dermis is dominated by the extracellular matrix, where Type I and Type III collagens provide tensile strength and elastin fibers confer elasticity and resilience (NIH, 2022). In the epidermis, keratins and the protein filaggrin are essential for maintaining the cornified envelope, which serves as the primary chemical and physical barrier against environmental insults and water loss (PubMed, 2021). These components are not only vital for mechanical integrity but also play active roles in cell signaling and wound healing processes. Pathological alterations in these structural elements lead to a variety of conditions, such as premature aging, scleroderma, and genetic blistering diseases like epidermolysis bullosa (Journal of Investigative Dermatology, 2020). Pharmacological strategies often involve the use of retinoids to upregulate collagen production, the application of hyaluronic acid for volume restoration, or the use of collagenase enzymes to treat fibroproliferative disorders (PubChem, 2023).

Other names

Dermal matrix componentsExtracellular matrix of the skinEpidermal barrier proteinsSkin structural proteinsDermal ECM

Drugs targeting skin structural components typically work by either stimulating the biosynthetic pathways of fibroblasts to increase the production of collagen and elastin, providing exogenous replacement of matrix components like hyaluronic acid, or utilizing proteolytic enzymes to break down pathological accumulations of structural proteins (StatPearls, 2023; PubChem, 2023).